Joly, Bérangère S.
Zheng, X. Long
Veyradier, Agnès
Article History
Received: 4 November 2017
Accepted: 11 January 2018
First Online: 24 January 2018
Compliance with ethical standards
:
: BSJ is recipient of the MaRIH research grant Alexion 2016; AV is a member of the French Advisory board on Caplacizumab (Ablynx); XLZ is a consultant for Ablynx and a member of the speakers’ bureau for Alexion.